Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Construction in Progress (2020 - 2021)

Rani Therapeutics Holdings has reported Construction in Progress over the past 2 years, most recently at $3.5 million for Q4 2021.

  • Quarterly results put Construction in Progress at $3.5 million for Q4 2021, changed 0.0% from a year ago — trailing twelve months through Dec 2021 was $3.5 million (changed 0.0% YoY), and the annual figure for FY2021 was $3.5 million, changed 0.0%.
  • Construction in Progress for Q4 2021 was $3.5 million at Rani Therapeutics Holdings, roughly flat from $3.5 million in the prior quarter.
  • Over the last five years, Construction in Progress for RANI hit a ceiling of $3.5 million in Q4 2020 and a floor of $3.5 million in Q4 2020.